The RADMED monitoring program as a tool for MSFD implementation: toward an ecosystem based approach

In the western Mediterranean Sea, the RADMED monitoring programme is already conducting several of the evaluations required under the Marine Strategy Framework Directive (MFSD) along the Spanish Mediterranean coast. The different aspects of the ecosystem that are regularly sampled under this monitoring programme are the physical environment and the chemical and biological variables of the water column, together with the planktonic communities, biomass and structure. Moreover, determinations of some anthropogenic stressors on the marine environment, such as contaminants and microplastics, are under development. Data are managed and stored at the Instituto Español de Oceanografía (IEO) Data Centre that works under the Sea- DataNet infrastructure, and are also stored in the IBAMar database. In combination with remote sensing data, they are used to address open questions on the ecosystems in the western Mediterranean Sea.Postprint2,293

Protocolos RADMED (versión: 1.01 – 2014). Procedimientos a seguir en las campañas del proyecto RADMED

Los protocolos RADMED se pueden considerar como una guía de mar de las operaciones a realizar en el desarrollo de una campaña de ese proyecto, en donde figuran: el montaje del equipamiento científico, las secuencias de las diferentes operaciones y muestreos, la identificación de las estaciones, cómo rellenar los diferentes estadillos, las determinaciones de variables oceanográficas a bordo y el post-procesado de los datos hidrográficos. Detrás de todo ello está la intención de homogeneizar la información, para facilitar el post-procesado y el fiel tratamiento de las muestras y análisis.[Abstract] The RADMED protocols can be considered as a guide to work at the sea in the development of a campaign of this project and to conduct its different operations. They include: installation of scientific equipment, the sequences of the different operations and sampling, identification of stations, the filling of the various work sheets, determinations of oceanographic variables on board and the post processing of hydrographic data. All this pretend to standardize the information to facilitate post processing and accurate treatment of the samples and analysis

Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study

: The identification of high-risk patients in the early stages of infected pancreatic necrosis (IPN) is critical, because it could help the clinicians to adopt more effective management strategies. We conducted a post hoc analysis of the MANCTRA-1 international study to assess the association between clinical risk factors and mortality among adult patients with IPN. Univariable and multivariable logistic regression models were used to identify prognostic factors of mortality. We identified 247 consecutive patients with IPN hospitalised between January 2019 and December 2020. History of uncontrolled arterial hypertension (p = 0.032; 95% CI 1.135-15.882; aOR 4.245), qSOFA (p = 0.005; 95% CI 1.359-5.879; aOR 2.828), renal failure (p = 0.022; 95% CI 1.138-5.442; aOR 2.489), and haemodynamic failure (p = 0.018; 95% CI 1.184-5.978; aOR 2.661), were identified as independent predictors of mortality in IPN patients. Cholangitis (p = 0.003; 95% CI 1.598-9.930; aOR 3.983), abdominal compartment syndrome (p = 0.032; 95% CI 1.090-6.967; aOR 2.735), and gastrointestinal/intra-abdominal bleeding (p = 0.009; 95% CI 1.286-5.712; aOR 2.710) were independently associated with the risk of mortality. Upfront open surgical necrosectomy was strongly associated with the risk of mortality (p < 0.001; 95% CI 1.912-7.442; aOR 3.772), whereas endoscopic drainage of pancreatic necrosis (p = 0.018; 95% CI 0.138-0.834; aOR 0.339) and enteral nutrition (p = 0.003; 95% CI 0.143-0.716; aOR 0.320) were found as protective factors. Organ failure, acute cholangitis, and upfront open surgical necrosectomy were the most significant predictors of mortality. Our study confirmed that, even in a subgroup of particularly ill patients such as those with IPN, upfront open surgery should be avoided as much as possible. Study protocol registered in ClinicalTrials.Gov (I.D. Number NCT04747990)

Importancia de la ciclooxygenasa-2 en el control de la función renal / Francisca Rodríguez Mulero ; Directores: F. Javier Salazar Aparicio, María Teresa Llinás Más.

Tesis - Universidad de Murcia.MEDICINA ESPINARDO. DEPOSITO. MU-Tesis 581.Consulte la tesis en: BCA. GENERAL. ARCHIVO UNIVERSITARIO. T.M.-1794

Red de Investigación del 2º Curso del Grado de Arquitectura Técnica. Acciones de mejora derivadas del seguimiento, evaluación y acreditación

Esta red coordina las asignaturas del 2º Curso del Grado de Arquitectura Técnica y se han realizado por orden cronológico distintas acciones de mejora para la docencia Universitaria. Primero, se ha editado un cuaderno de la titulación del Grado de Arquitectura Técnica para informar al estudiante, de nueva incorporación y a los que siguen los estudios, sobre lo que van a aprender en las asignaturas de cada curso. Segundo, se ha realizado una visita guiada por técnicos de la empresa constructora y por profesores pertenecientes a esta red a varias obras de rehabilitación que están llevando a cabo en la localidad de San Juan. Tercero, se ha realizado un Concurso de Estructuras. Cuarto, se ha realizado una revisión bibliográfica sobre la implantación de BIM (Building Information Modelling) en los estudios superiores de Ingeniería Civil y Arquitectura en distintas Universidades Nacionales e Internacionales. Quinto, se han realizado varias propuestas de TFG aplicadas al ámbito del Cálculo de las Estructuras relacionadas con BIM. Sexto, se convoca una reunión presencial al final del curso para comentar resultados, dificultades y propuestas de mejora de las asignaturas. La finalidad de este conjunto de acciones ha sido intentar motivar al estudiante y mejorar la docencia de la Titulación del Grado

Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

The objective of this work is to analyze the survival of infliximab, etanercept and adalimumab in patients who have switched among tumor necrosis factor (TNF) antagonists for the treatment of chronic arthritis. BIOBADASER is a national registry of patients with different forms of chronic arthritis who are treated with biologics. Using this registry, we have analyzed patient switching of TNF antagonists. The cumulative discontinuation rate was calculated using the actuarial method. The log-rank test was used to compare survival curves, and Cox regression models were used to assess independent factors associated with discontinuing medication. Between February 2000 and September 2004, 4,706 patients were registered in BIOBADASER, of whom 68% had rheumatoid arthritis, 11% ankylosing spondylitis, 10% psoriatic arthritis, and 11% other forms of chronic arthritis. One- and two-year drug survival rates of the TNF antagonist were 0.83 and 0.75, respectively. There were 488 patients treated with more than one TNF antagonist. In this situation, survival of the second TNF antagonist decreased to 0.68 and 0.60 at 1 and 2 years, respectively. Survival was better in patients replacing the first TNF antagonist because of adverse events (hazard ratio (HR) for discontinuation 0.55 (95% confidence interval (CI), 0.34-0.84)), and worse in patients older than 60 years (HR 1.10 (95% CI 0.97-2.49)) or who were treated with infliximab (HR 3.22 (95% CI 2.13-4.87)). In summary, in patients who require continuous therapy and have failed to respond to a TNF antagonist, replacement with a different TNF antagonist may be of use under certain situations. This issue will deserve continuous reassessment with the arrival of new medications. © 2006 Gomez-Reino and Loreto Carmona; licensee BioMed Central Ltd